Atlas market file · Equity · Asia-Pacific
New China Life Insurance Co., Ltd. Class A601336
- Last close
- 58.83
- Change
- +0.81%
- 96-bar range
- 55.01 – 67.16
- As of
- 12 Aug 2026
New China Life Insurance Co., Ltd. Class A is a financial issuer listed as 601336 on SSE. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
- Identity
- SSE symbol identity
- Chart rail
- TradingView
- File state
- Public profile
Static Daily candlestick snapshot from the approved cache, drawn on a labelled price axis: green bodies closed up, red closed down, wicks span each bar's high-to-low range. The live TradingView link stays available; the public profile never embeds a widget that can render the wrong symbol.
▮ up candle ▮ down candle
Weekly outlook: the last 104 weekly closes (+78.00% over the window).
Source rail: Yahoo Finance chart API (601336.SS). This dated snapshot is the crawlable Atlas reference.
Live market viewTradingView · provider feed Open view ->
Open the attributed TradingView market view for 601336. The dated Atlas snapshot above remains the crawlable reference; exchange data in this panel may be live or delayed as labelled by TradingView.
601336 public profile
Financial issuer. New China Life Insurance Co., Ltd. Class A is connected to current market context, cited company sources and its retained research file.
New China Life Insurance Co., Ltd. Class A trades as 601336 on SSE. New China Life Insurance Co., Ltd. Class A (601336) has a latest verified close of 58.83, up 0.81%, dated 12 Aug 2026.
Open the chart, inspect attributed company evidence and continue into the fuller research file without losing this market context. Atlas files 601336 under Financial Stocks for browsing.
What changed for New China Life Insurance Co., Ltd. Class A today
New China Life Insurance Co., Ltd. Class A (601336) remains a cornerstone of the Asia-Pacific life insurance sector, listed on the Shanghai Stock Exchange (SSE) with a market presence tied to China’s evolving demographic and regulatory environment. While official financial metrics remain un parsed in the current evidence, the company’s regional dominance and exposure to mainland China’s insurance demand position it as a key player in a market balancing growth against macroeconomic headwinds.
The insurer’s core business revolves around life insurance products, catering to a population navigating shifting savings habits and increasing demand for financial security. Its operations are closely monitored by domestic regulators, ensuring compliance with capital adequacy and risk management standards. However, the absence of concrete earnings data limits visibility into its current profitability and growth trajectory, leaving analysts to rely on broader sector trends and the company’s historical performance as guides.
TradingView’s SSE:601336 chart serves as a visual proxy for market sentiment, though without explicit financials, the technical analysis becomes a exercise in interpretation. The chart’s patterns-resistance levels, volume spikes, and moving averages-hint at underlying investor behavior but lack the grounding of official figures. This gap underscores the importance of awaiting formal disclosures to anchor technical observations in tangible operational realities.
Risks include regulatory shifts in China’s financial sector, competitive pressures from domestic peers, and macroeconomic volatility affecting premium collections. Catalysts could emerge from earnings releases, policy changes favoring insurance penetration, or improved transparency in financial reporting. For now, the stock’s story remains one of potential constrained by incomplete data, a narrative as much about patience as performance.
Sources & evidence · 1 links
This is the public answer layer. The full Atlas report adds the complete Market Wit archive, risk rail, catalyst map, final editor synthesis, PDF/CSV export, email delivery and saved history.
601336 technical readout
Directional bias up. Wilder ADX and ATR computed from Atlas approved daily OHLC through 2026-07-28. Indicators are descriptive statistics, not investment advice.
Open an Atlas research path on 601336
FreedomCore Atlas can expand this public profile into source-led research files with company snapshots, valuation context, filings and segment detail, source packs, and equity briefs. Each path keeps the underlying public sources visible.
Open Atlas workstation ->Keep 601336 research in your Atlas archive
Free Atlas includes the public profile and one owned welcome research artifact after account setup. Atlas Pro adds up to 25 custom research runs a day, a 500-symbol watchlist, saved report versions, and eligible PDF, CSV, and email artifacts. Evidence holds still apply and never become an unverified download. £12/month founding price, locked for life. Research only; not investment advice.
Checking Atlas access...
601336 FAQ
What is New China Life Insurance Co., Ltd. Class A (601336)?New China Life Insurance Co., Ltd. Class A (601336) has a latest verified close of 58.83, up 0.81%, dated 12 Aug 2026. Use this page to check the price chart, company...
New China Life Insurance Co., Ltd. Class A (601336) has a latest verified close of 58.83, up 0.81%, dated 12 Aug 2026. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
What does Atlas show for 601336?New China Life Insurance Co., Ltd. Class A (601336) has a latest verified close of 58.83, up 0.81%, dated 12 Aug 2026. It brings the latest available chart, company...
New China Life Insurance Co., Ltd. Class A (601336) has a latest verified close of 58.83, up 0.81%, dated 12 Aug 2026. It brings the latest available chart, company context, cited sources, risks and the route into the full Atlas research file together. Atlas files 601336 under Financial Stocks for browsing.
How often is the 601336 page updated?The 601336 public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows...
The 601336 public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the freshness of the current market snapshot.
Which sources does Atlas use for 601336?The 601336 file starts with SSE symbol identity and TradingView SSE:601336. The page separates verified market context from company evidence and shows open evidence...
The 601336 file starts with SSE symbol identity and TradingView SSE:601336. The page separates verified market context from company evidence and shows open evidence gaps instead of filling them with assumptions.
Can Atlas run a full research brief on 601336?Yes. The workstation can open 601336, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Yes. The workstation can open 601336, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Is this 601336 page investment advice?No. The 601336 page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a...
No. The 601336 page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise of returns.
Methodology
This profile is generated daily from public sources including SEC EDGAR (US-listed companies), NASDAQ Trader files, exchange listings, public macro/central-bank releases, CoinGecko crypto market files where relevant, and the TradingView global symbol catalog. Multi-model AI may assist drafting and review where configured, but sources remain the evidence rail; the chart is an Atlas static OHLC rail with a live TradingView link when verified bars are available; otherwise the page keeps the verified TradingView route as an explicit fallback.
Research only. Not investment advice. No brokerage execution. No guaranteed returns are promised or implied. FreedomCore does not provide personalised investment advice. Always consult a regulated financial advisor before making investment decisions.
Profile last updated: 2026-08-07. Browse FreedomCore Atlas research notes →
601336
Equity · evidence first